Trial Profile
The Comparison of the Cardiovascular Effects of Remifentanil and Nitroprusside for Controlled Hypotension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2013
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary) ; Sodium nitroprusside (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 11 Dec 2013 New trial record